We aimed to determine how MeCP2 level and chromatin clustering influence nuclear stiffness, particularly in the context of cellular differentiation and disease models, including Rett syndrome, and to assess the role of mechanotransduction pathways in these processes. This evidence concerns the gene MECP2 and atypical Rett syndrome.